Allurion Technologies (ALUR) Cash from Operations (2022 - 2026)
Allurion Technologies (ALUR) posted Cash from Operations of 3221000.0 for Q1 2026, up 39.45% on a QoQ basis from 5320000.0 in Q4 2025, and up 65.98% year-over-year from 1940551.57 in Q1 2025.
Allurion Technologies (ALUR) Cash from Operations (2022 - 2026) Analysis & Trends
Allurion Technologies' Cash from Operations history runs 5 years deep, the most recent figure standing at 3221000.0 for Q1 2026.
- Quarterly Cash from Operations rose 65.98% year-over-year to 3221000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 22698000.0 (up 47.42% YoY) and the FY2025 annual result came in at 28946000.0, up 31.57% from the prior year.
- Cash from Operations was 3221000.0 for Q1 2026 at Allurion Technologies, up from 5320000.0 in the prior quarter.
- Across five years, Cash from Operations topped out at 3221000.0 in Q1 2026 and bottomed at 23083000.0 in Q3 2023.
- A 5-year average of 10955933.33 and a median of 9717000.0 in 2023 frame the typical range for Cash from Operations.
- Annual changes were most pronounced in 2023 — Cash from Operations plunged 127.94% — and 2026, when it soared 65.98%.
- Allurion Technologies' Cash from Operations stood at 15745000.0 in 2022, then plunged by 32.74% to 20900000.0 in 2023, then surged by 36.49% to 13274000.0 in 2024, then surged by 59.92% to 5320000.0 in 2025, then jumped by 39.45% to 3221000.0 in 2026.
- Business Quant data shows ALUR's Cash from Operations at 3221000.0 in Q1 2026, 5320000.0 in Q4 2025, and 6526000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.32 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 581.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 2.57 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 348.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 43.80 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 525.60 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 220.10 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 290.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Allurion Technologies | 74.67 Mn | 69.62 Mn | 1.23 Mn | -3.22 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.22 Mn |
| Mar 31, 2026 | -3.22 Mn |
| Dec 31, 2025 | -5.32 Mn |
| Dec 31, 2025 | -5.32 Mn |
| Sep 30, 2025 | -6.53 Mn |
| Sep 30, 2025 | -6.53 Mn |
| Jun 30, 2025 | -7.63 Mn |
| Jun 30, 2025 | -7.63 Mn |
| Mar 31, 2025 | -9.47 Mn |
| Mar 31, 2025 | -9.47 Mn |
| Dec 31, 2024 | -13.27 Mn |
| Dec 31, 2024 | -13.27 Mn |
| Sep 30, 2024 | -11.43 Mn |
| Sep 30, 2024 | -11.43 Mn |
| Jun 30, 2024 | -9.00 Mn |
| Jun 30, 2024 | -9.00 Mn |
| Mar 31, 2024 | -8.60 Mn |
| Mar 31, 2024 | -8.60 Mn |
| Dec 31, 2023 | -20.90 Mn |
| Dec 31, 2023 | -20.90 Mn |